SCHEMBL23047312

SCHEMBL23047312

CC(C)S(=O)(=O)c1ccc(-c2nn(-c3ccc(NC/C=C(\ON)C(C)(C)C)cc3)c3ncnc(N)c23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 2/20 0.45
▸ SRC P12931 10/20 0.42
▸ EGFR P00533 5/20 0.42
▸ HCK P08631 5/20 0.42
▸ PIK3CD O00329 4/20 0.42
▸ ABL1 P00519 4/20 0.42
▸ KDR P35968 4/20 0.42
▸ PIK3CA P42336 4/20 0.42
▸ MTOR P42345 4/20 0.42
▸ PIK3CG P48736 4/20 0.42
▸ EPHB4 P54760 4/20 0.42
▸ PRKDC P78527 4/20 0.42
▸ PI4KB Q9UBF8 4/20 0.42
▸ PIK3CB P42338 3/20 0.41
▸ RET P07949 3/20 0.41
▸ LCK P06239 2/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ PDGFRA P16234 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19683789 0.79 BTK (0.41) ATRSRCEGFRHCKABL1
SCHEMBL19683815 0.79 LCK (0.64) SRCEGFRHCKPIK3CDKDR
SCHEMBL20873190 0.75 FLT3 (0.66) RETLCKCSF1RPDGFRBKIT
SCHEMBL20878854 0.74 SRC (0.40) ATRSRCEGFRHCKPIK3CD
SCHEMBL19683625 0.68 FLT3 (0.65) RETLCKCSF1RPDGFRBKIT
SCHEMBL20873203 0.66 FLT3 (0.66) RETLCKCSF1RPDGFRBKIT
SCHEMBL19683615 0.66 FLT3 (0.68) RETLCKCSF1RPDGFRBKIT
SCHEMBL19683620 0.66 FLT3 (0.68) RETLCKCSF1RPDGFRBKIT
SCHEMBL23047333 0.66 FLT3 (0.47) ATRSRCEGFRHCKPIK3CD
SCHEMBL14574734 0.65 SRC (0.60) ATRSRCEGFRHCKPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466952-B1 1-(4-(4-AMINO-3-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)-PHENYL)-UREA DERIVATIVES AS FLT3 KINASE INHIBITORS FOR TREATING CANCER PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-03-03 — — EP disclosed
Send feedback